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Conclusion: LM-VH-TCFA are clustered in mid-body of the left main artery with
infrequent positive remodeling.
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Background: Optical coherence tomography (OCT) of a bioresorbable vascular
scaffold (BVS) produces a highly reflective signal outlining struts. This signal
interferes with the measurement of strut thickness, as the boundaries cannot be
accurately identified, and with the assessment of coverage, because the neointimal
backscattering convolutes that of the polymer, frequently making them
indistinguishable from one another. We hypothesize that Gaussian line spread functions
(LSFs) can facilitate identification of strut boundaries, improving the accuracy of strut
thickness measurements and coverage assessment.
Methods: 48 randomly selected BVS struts from 12 patients in the ABSORB Cohort
B clinical study and 4 Yucatan minipigs were analyzed at baseline and follow-up (6
months in humans, 28 days in pigs). Signal intensities from the raw OCT backscattering
were fit to Gaussian LSFs for each interface, from which peak intensity and full-width-
at-half-maximum (FWHM) were calculated.
Results: Neointimal coverage resulted in significantly different LSFs and higher
FWHM values relative to uncovered struts at baseline (p<0.0001). Abluminal polymer-
tissue interfaces were also significantly different between baseline and follow-up
(p=0.0004 in humans, p<0.0001 in pigs). Using the location of the half-max of the LSF
as the polymer-tissue boundary, the average strut thickness was 158 ± 11 μm at baseline
and 152 ± 20 μm at 6 months (p=0.886), not significantly different from nominal strut
thickness.
Conclusion: Fitting the raw OCT backscattering signal to a Gaussian LSF facilitates
identification of the interfaces between BVS polymer and lumen or tissue. Such
analysis enables more precise measurement of the strut thickness and an objective
assessment of coverage.
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Background: Intravascular ultrasound-derived echogenicity analyses have been used
to estimate the degradation of the ABSORB scaffold in the ABSORB trials. Coronary
arterial remodeling and baseline IVUS morphology of the scaffolded plaque may be
related to the subsequent degradation of the ABSORB scaffold. We sough to analyze
the changes in ultrasound characteristics of the ABSORB scaffold in relationship to
the baseline IVUS morphology and remodeling pattern of the plaque scaffolded.
Methods: The study population consisted of all patients with available echogenicity
analyses at baseline and 6 (n=28) or 12 (n=35) months follow-up. Coronary remodeling
was evaluated for the scaffolded segments by the serial assessment of changes in
atheroma and EEM areas and classified as positive (PR), incomplete (IR) or negative
(NR) remodeling. Baseline plaque morphology was visually assessed by IVUS in each
cross-sectional area as calcified, fibro-necrotic or fibro-cellular.
Results: At 6 months no changes in hyper-echogenicity were found between the
baseline IVUS plaque morphology and various patterns of remodeling. At 12 months,
plaques scaffolded with PR were associated with a larger reduction in hyper-
echogenicity (median [95%CI] -30.56%[-38.92 – -20.43]) compared with IR
(-19.40%[-25.57 – -5.01]) or NR (-1.18%[-17.25 – 7.03]; p=0.017). At 12 months, a
trend toward a greater reduction in hyper-echogenicity in calcified plaques compared
to the other types was evident (calcified plaques -20.48%[-30.32 – -10.65] vs. fibro-
necrotic plaques -14.54%[-23.12 – -5.97] vs. fibro-cellular plaques -8.61[-19.71 –
2.49], p=0.054).
Conclusion: At 12 months, baseline IVUS morphology and positive remodeling of
the plaque scaffolded appear to influence the reduction in ultrasound material
parameters of the ABSORB scaffold. The two years results will be available at the time
of the presentation.
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Background: Advanced imaging modalities provide various findings in unstable
plaque in the coronary arteries. Optical coherence tomography (OCT) evaluates thin-
cap fibroatheroma (TCFA); whereas biomarkers reflect pathological process of
cardiovascular disease (CVD), such as unstable plaque, plaque rupture and thrombus
formation in acute coronary syndrome. The association between unstable plaque and
biomarkers has not been elucidated in vivo. Here, this study aimed to evaluate the
correlation between biomarkers (interleukin-6, IL-6; matrix metalloproteinase-9,
MMP-9, high sensitive C-reactive protein, hs-CRP) and plaque morphology using OCT
and to investigate the usefulness of these biomarkers for early risk stratification.
Methods: This study included 46 CVD patients (26 ACS patients and 20 patients with
effort angina pectoris; EAP) who underwent percutaneous coronary intervention (PCI).
Blood samples were collected before PCI. Culprit lesions were identified using
electrocardiography, coronary angiography, cardiac scintigraphy and pressure wire.
OCT was performed before stent implantation for assessing fibrous cap thickness,
TCFA (plaque burden >2 quadrant, fibrous cap measurement <80μm), and the presence
/ absence of thrombus and plaque rupture.
Results: Hs-CRP was significantly higher in ACS patients than EAP patients
(0.313±0.094 vs. 0.073±0.011mg/dl, p=0.16). The patients with TCFA had significantly
higher hs-CRP (0.332±0.108mg/dl vs. 0.086±0.019mg/dl, p=0.16) and IL-6
(14.16±7.43pg/ml vs. 3.72±1.39pg/dl, p=0.47) than those without TCFA. Fibrous cap
thickness was significantly thinner (80.8±12.2μm vs.177.5±18.8μm, p<0.001) and
plaque rapture and thrombus were significantly greater in ACS patients than EAP
patients. Fibrous cap thickness correlated with hs-CRP (r =-0.37, p=0.037) but not
correlated with IL-6 (r=-0.175, p=0.39) or MMP-9 (r=-0.117, p=0.354). The receiver
operator characteristic (ROC) curves resulted that the specificities and sensitivities of
hs-CRP and IL-6 were 70% and 72% (cut off at 0.081mg/dl) and 70% and 73% (cut
off at 1.81pg/ml), respectively, suggesting that these biomarkers probably identify
TCFA.
Conclusion: Hs-CRP and IL-6 were predictors of unstable plaque assessed with OCT.
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Background: We assessed culprit lesions of infarct-related arteries (IRA) using Virtual
Histology Intravascular Ultrasound (VH-IVUS) in 112 pts with acute ST elevation
myocardial infarction (STEMI).
Methods: STEMI pts were divided into 2 groups: IRA with total occlusion (TOI, n=67)
and partial-occluded IRA(POI, n=45). TIMI thrombus grade was evaluated: Gr 0, no
angiographic thrombus; Gr 1, possible thrombus; Gr 2, definite thrombus with greatest
dimensions ≤1/2 the vessel diameter(VD); Gr 3, definite thrombus with greatest
dimension 1/2 to 2 VD; Gr 4, definite thrombus with the largest dimension ≥2 VD;
and Gr 5; total occlusion. VH-thin-capped fibroatheroma (VH-TCFAs) was defined as
necrotic core (NC) >10% of plaque area, plaque burden >40%, and NC in contact with
the lumen for ≥3 image slices. Positive remodeling was defined as lesion/reference
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